Literature DB >> 18397489

Clinicopathological features of gastric cancer detected by endoscopy as part of annual health checkup.

Kayo Aida1, Hiroyuki Yoshikawa, Chihiro Mochizuki, Atsuyoshi Mori, Shigeki Muto, Takanori Fukuda, Makoto Otsuki.   

Abstract

BACKGROUND AND AIM: Upper gastrointestinal endoscopy is generally accepted as the gold standard for the clinical evaluation of gastric cancer (GC). However, the efficacy of endoscopic screening for asymptomatic GC remains controversial. The present study is designed to clarify the efficacy of endoscopic screening for the detection of early GC by investigating the clinicopathological features.
METHODS: A total of 17 522 patients who had underwent endoscopic screening as a part of their annual health checkup at the Seirei Center for Health Promotion and Preventive Medicine between April 2002 and March 2006 were enrolled in this study. We investigated the clinicopathological findings of GC detected by endoscopy. Furthermore, in accordance with the screening interval at our center, patients with GC were categorized into two groups: group A, patients with repeated endoscopic screening within the last 2 years, and group B, patients without endoscopic screening within the last 2 years.
RESULTS: Thirty-nine GC (mean age of patients: 62.2 +/- 8.0 years, 36 males and three females) were detected in total (0.22%). The proportion of early GC was 87.2%. Notable differences between groups A and B were not found in the rate of early GC (P = 0.6342). However, eight of 27 cases (29.6%) in group A were treated by endoscopic resection, but none in group B (P = 0.0344). In six of 26 cases (23.1%) in group A, the recorded images from the previous endoscopic examination indicated some macroscopic abnormalities at the same location, suggesting GC or premalignant lesions.
CONCLUSION: Endoscopic screening is useful for detecting GC at the early stages, and repeated examinations at short-time intervals contribute to the detection of resectable lesions by endoscopy. Further studies are needed to decrease the false negative rate of endoscopic screening.

Entities:  

Mesh:

Year:  2008        PMID: 18397489     DOI: 10.1111/j.1440-1746.2008.05346.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  10 in total

1.  Risk factors of developing interval early gastric cancer after negative endoscopy.

Authors:  Young Sin Cho; Il-Kwun Chung; Ji Hyun Kim; Yunho Jung; Tae Hoon Lee; Sang-Heum Park; Sun-Joo Kim
Journal:  Dig Dis Sci       Date:  2014-10-15       Impact factor: 3.199

Review 2.  Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention.

Authors:  Parisa Karimi; Farhad Islami; Sharmila Anandasabapathy; Neal D Freedman; Farin Kamangar
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-03-11       Impact factor: 4.254

3.  Risk factors for the failure of endoscopic resection of gastric submucosal tumors: a long-term retrospective case-control study.

Authors:  Yuzhu Yuan; Lixin Sun; Xiaoying Zhou; Han Chen; Xinmin Si; Weifeng Zhang; Yun Wang; Bixing Ye; Nana Tang; Guoxin Zhang; Xueliang Li; Hongjie Zhang; Chunhua Jiao
Journal:  Gastric Cancer       Date:  2022-06-26       Impact factor: 7.701

4.  Normalized autofluorescence imaging diagnostics in upper GI tract: a new method to improve specificity in neoplasia detection.

Authors:  Ekaterina Krauss; Abbas Agaimy; Alexandre Douplik; Heinz Albrecht; Helmut Neumann; Arndt Hartmann; Ralf Hohenstein; Martin Raithel; Eckhart G Hahn; Markus F Neurath; Jonas Mudter
Journal:  Int J Clin Exp Pathol       Date:  2012-10-20

5.  Risk factors of atrophic gastritis and intestinal metaplasia in first-degree relatives of gastric cancer patients compared with age-sex matched controls.

Authors:  Sooyeon Oh; Nayoung Kim; Hyuk Yoon; Yun Jin Choi; Ju Yup Lee; Kyoung Jun Park; Hee Jin Kim; Kyu Keun Kang; Dong Hyun Oh; A Young Seo; Jae Woo Lee; Cheol Min Shin; Young Soo Park; Jane C Oh; Dong Ho Lee; Hyun Chae Jung
Journal:  J Cancer Prev       Date:  2013-06

6.  Prevalence of Precancerous Conditions and Gastric Cancer Based upon the National Cancer Screening Program in Korea for 7 Years, Single Center Experience.

Authors:  Ji Hyuk Kang; Yun Jeong Lim; Jung Hyun Kang; Jae Nam Yang; Seung Min Shin; Jae Hyeuk Choi; Jin Ho Lee
Journal:  Gastroenterol Res Pract       Date:  2015-01-06       Impact factor: 2.260

Review 7.  Gastric cancer and family history.

Authors:  Yoon Jin Choi; Nayoung Kim
Journal:  Korean J Intern Med       Date:  2016-11-01       Impact factor: 2.884

8.  Optimal Interval for Repeated Gastric Cancer Screening in Normal-Risk Healthy Korean Adults: A Retrospective Cohort Study.

Authors:  Jong-Myon Bae; Sang Yop Shin; Eun Hee Kim
Journal:  Cancer Res Treat       Date:  2015-01-30       Impact factor: 4.679

Review 9.  The stomach in health and disease.

Authors:  R H Hunt; M Camilleri; S E Crowe; E M El-Omar; J G Fox; E J Kuipers; P Malfertheiner; K E L McColl; D M Pritchard; M Rugge; A Sonnenberg; K Sugano; J Tack
Journal:  Gut       Date:  2015-09-04       Impact factor: 23.059

10.  Efficacy of i-Scan Imaging for the Detection and Diagnosis of Early Gastric Carcinomas.

Authors:  Junichi Nishimura; Jun Nishikawa; Munetaka Nakamura; Atsushi Goto; Kouichi Hamabe; Shinichi Hashimoto; Takeshi Okamoto; Masato Suenaga; Yusuke Fujita; Yoshihiko Hamamoto; Isao Sakaida
Journal:  Gastroenterol Res Pract       Date:  2014-03-09       Impact factor: 2.260

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.